<DOC>
	<DOC>NCT00562614</DOC>
	<brief_summary>The purpose is to determine the effect of SLx-2101 dosed at 5mg or 10mg for 14 days on systolic, diastolic pressures and heart rate in patients with hypertension.</brief_summary>
	<brief_title>Safety and Effect of Oral Doses of 5mg or 10mg of SLx-2101 for 14 Days in Patients With Hypertension</brief_title>
	<detailed_description>1. Placebo-corrected supine peripheral systolic, diastolic blood pressures and heart rate 2. 24 hour ambulatory blood pressure and heart rate 3. Safety and tolerability</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<criteria>Male or female subjects between 18 and 70 years old, inclusive Moderate to severe hypertension Body weight within a body mass index of 1832kg/m2 The subject is receiving more than three antihypertensive agents A history of drug abuse Exposure to a new chemical entity within 3 months prior to the first day of dosing</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>